TY - JOUR
T1 - Reliability and discriminant validity of ataxia rating scales in early onset ataxia
AU - Brandsma, Rick
AU - Lawerman, Tjitske F.
AU - Kuiper, Marieke J.
AU - Lunsing, Roelineke J.
AU - Burger, Huibert
AU - Sival, Deborah A.
PY - 2017/4
Y1 - 2017/4
N2 - AIM To determine whether ataxia rating scales are reliable disease biomarkers for early onset ataxia (EOA).METHOD In 40 patients clinically identified with EOA (28 males, 12 females; mean age 15y 3mo [range 5-34y]), we determined interobserver and intraobserver agreement (interclass correlation coefficient [ICC]) and discriminant validity of ataxia rating scales (International Cooperative Ataxia Rating Scale [ICARS], Scale for Assessment and Rating of Ataxia [SARA], and Brief Ataxia Rating Scale [BARS]). Three paediatric neurologists independently scored ICARS, SARA and BARS performances recorded on video, and also phenotyped the primary and secondary movement disorder features. When ataxia was the primary movement disorder feature, we assigned patients to the subgroup ' EOA with core ataxia ' (n=26). When ataxia concurred with other prevailing movement disorders (such as dystonia, myoclonus, and chorea), we assigned patients to the subgroup ' EOA with comorbid ataxia ' (n=12).RESULTS ICC values were similar in both EOA subgroups of ' core ' and ' comorbid ' ataxia (0.92-0.99; ICARS, SARA, and BARS). Independent of the phenotype, the severity of the prevailing movement disorder predicted the ataxia rating scale scores (beta=0.83-0.88; p <0.05).INTERPRETATION In patients with EOA, the reliability of ataxia rating scales is high. However, the discriminative validity for ' ataxia ' is low. For adequate interpretation of ataxia rating scale scores, application in uniform movement disorder phenotypes is essential.
AB - AIM To determine whether ataxia rating scales are reliable disease biomarkers for early onset ataxia (EOA).METHOD In 40 patients clinically identified with EOA (28 males, 12 females; mean age 15y 3mo [range 5-34y]), we determined interobserver and intraobserver agreement (interclass correlation coefficient [ICC]) and discriminant validity of ataxia rating scales (International Cooperative Ataxia Rating Scale [ICARS], Scale for Assessment and Rating of Ataxia [SARA], and Brief Ataxia Rating Scale [BARS]). Three paediatric neurologists independently scored ICARS, SARA and BARS performances recorded on video, and also phenotyped the primary and secondary movement disorder features. When ataxia was the primary movement disorder feature, we assigned patients to the subgroup ' EOA with core ataxia ' (n=26). When ataxia concurred with other prevailing movement disorders (such as dystonia, myoclonus, and chorea), we assigned patients to the subgroup ' EOA with comorbid ataxia ' (n=12).RESULTS ICC values were similar in both EOA subgroups of ' core ' and ' comorbid ' ataxia (0.92-0.99; ICARS, SARA, and BARS). Independent of the phenotype, the severity of the prevailing movement disorder predicted the ataxia rating scale scores (beta=0.83-0.88; p <0.05).INTERPRETATION In patients with EOA, the reliability of ataxia rating scales is high. However, the discriminative validity for ' ataxia ' is low. For adequate interpretation of ataxia rating scale scores, application in uniform movement disorder phenotypes is essential.
KW - HEREDITARY CEREBELLAR-ATAXIA
KW - FRIEDREICHS-ATAXIA
KW - CHILDREN
KW - POPULATION
KW - PREVALENCE
KW - RILUZOLE
KW - SARA
U2 - 10.1111/dmcn.13291
DO - 10.1111/dmcn.13291
M3 - Article
C2 - 27767206
SN - 0012-1622
VL - 59
SP - 427
EP - 432
JO - Developmental Medicine and Child Neurology
JF - Developmental Medicine and Child Neurology
IS - 4
ER -